{"transactions":[{"id":4628848,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":32942,"kind":"person","name":"Dar Zavain","position":1,"cik":"0001852075","reported_name":"Dar Zavain","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-10-02T22:17:44.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":4607,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":245371,"source":{"system":"sec-edgar","filing":"0001601830-26-000116","document":"wk-form4_1790979462.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852075/000160183026000116/wk-form4_1790979462.xml","form_type":"4"}},{"id":718250,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":32942,"kind":"person","name":"Dar Zavain","position":1,"cik":"0001852075","reported_name":"Dar Zavain","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-07-02T21:15:51.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":5109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":240764,"source":{"system":"sec-edgar","filing":"0001601830-26-000092","document":"wk-form4_1783026949.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852075/000160183026000092/wk-form4_1783026949.xml","form_type":"4"}},{"id":730639,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":32942,"kind":"person","name":"Dar Zavain","position":1,"cik":"0001852075","reported_name":"Dar Zavain","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-22T20:32:13.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":88424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units automatically granted pursuant to the Issuer's Outside Director Compensation Policy. The restricted stock units will vest on the earlier of June 17,2027 or the day prior to the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":235655,"source":{"system":"sec-edgar","filing":"0001601830-26-000084","document":"wk-form4_1782160331.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852075/000160183026000084/wk-form4_1782160331.xml","form_type":"4"}},{"id":819810,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":32942,"kind":"person","name":"Dar Zavain","position":1,"cik":"0001852075","reported_name":"Dar Zavain","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-04-02T20:56:26.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":4902,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":147231,"source":{"system":"sec-edgar","filing":"0001852075-26-000004","document":"wk-form4_1775163383.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852075/000185207526000004/wk-form4_1775163383.xml","form_type":"4"}},{"id":947008,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":32942,"kind":"person","name":"Dar Zavain","position":1,"cik":"0001852075","reported_name":"Dar Zavain","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-01-06T22:47:51.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":3571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":142329,"source":{"system":"sec-edgar","filing":"0001852075-26-000002","document":"wk-form4_1767739668.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852075/000185207526000002/wk-form4_1767739668.xml","form_type":"4"}},{"id":1024783,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":32942,"kind":"person","name":"Dar Zavain","position":1,"cik":"0001852075","reported_name":"Dar Zavain","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-10-03T20:27:30.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":2941,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":138758,"source":{"system":"sec-edgar","filing":"0001852075-25-000005","document":"wk-form4_1759523248.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852075/000185207525000005/wk-form4_1759523248.xml","form_type":"4"}},{"id":1092668,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":32942,"kind":"person","name":"Dar Zavain","position":1,"cik":"0001852075","reported_name":"Dar Zavain","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-07-03T19:30:17.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":2924,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":135817,"source":{"system":"sec-edgar","filing":"0001601830-25-000115","document":"wk-form4_1751571010.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852075/000160183025000115/wk-form4_1751571010.xml","form_type":"4"}},{"id":1103926,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":32942,"kind":"person","name":"Dar Zavain","position":1,"cik":"0001852075","reported_name":"Dar Zavain","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-23T21:23:13.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":44031,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option will vest and become exercisable on the earlier of June 18, 2026 or the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":44031,"derivative":{"exercise_price":5.11,"expiration_date":"2035-06-18","underlying":"Class A Common Stock","underlying_shares":44031},"source":{"system":"sec-edgar","filing":"0001601830-25-000109","document":"wk-form4_1750713786.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1852075/000160183025000109/wk-form4_1750713786.xml","form_type":"4"}},{"id":1103925,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":32942,"kind":"person","name":"Dar Zavain","position":1,"cik":"0001852075","reported_name":"Dar Zavain","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-23T21:23:13.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":22016,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units automatically granted pursuant to the Issuer's Outside Director Compensation Policy. The restricted stock units will vest on the earlier of June 18, 2026 or the day prior to the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":132893,"source":{"system":"sec-edgar","filing":"0001601830-25-000109","document":"wk-form4_1750713786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852075/000160183025000109/wk-form4_1750713786.xml","form_type":"4"}},{"id":1179978,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":32942,"kind":"person","name":"Dar Zavain","position":1,"cik":"0001852075","reported_name":"Dar Zavain","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-04-03T20:37:01.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":2745,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":110877,"source":{"system":"sec-edgar","filing":"0001601830-25-000055","document":"wk-form4_1743712590.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852075/000160183025000055/wk-form4_1743712590.xml","form_type":"4"}},{"id":1310981,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":32942,"kind":"person","name":"Dar Zavain","position":1,"cik":"0001852075","reported_name":"Dar Zavain","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-01-06T23:02:50.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":1907,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":108132,"source":{"system":"sec-edgar","filing":"0001601830-25-000006","document":"wk-form4_1736204565.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852075/000160183025000006/wk-form4_1736204565.xml","form_type":"4"}},{"id":1390841,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":32942,"kind":"person","name":"Dar Zavain","position":1,"cik":"0001852075","reported_name":"Dar Zavain","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-10-04T22:30:19.000Z","date":"2024-10-01","kind":"grant","planned":false,"acquired":true,"shares":2229,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":106225,"source":{"system":"sec-edgar","filing":"0001601830-24-000173","document":"wk-form4_1728081013.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852075/000160183024000173/wk-form4_1728081013.xml","form_type":"4"}},{"id":1460314,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":32942,"kind":"person","name":"Dar Zavain","position":1,"cik":"0001852075","reported_name":"Dar Zavain","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-07-03T20:39:55.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":1843,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":103996,"source":{"system":"sec-edgar","filing":"0001601830-24-000098","document":"wk-form4_1720039188.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852075/000160183024000098/wk-form4_1720039188.xml","form_type":"4"}},{"id":1490236,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":32942,"kind":"person","name":"Dar Zavain","position":1,"cik":"0001852075","reported_name":"Dar Zavain","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-05T22:11:43.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":26193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option will vest and become exercisable on the earlier of June 3, 2025 or the date of the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":26193,"derivative":{"exercise_price":8.59,"expiration_date":"2034-06-03","underlying":"Class A Common Stock","underlying_shares":26193},"source":{"system":"sec-edgar","filing":"0001601830-24-000070","document":"wk-form4_1717625489.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1852075/000160183024000070/wk-form4_1717625489.xml","form_type":"4"}},{"id":1490235,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":32942,"kind":"person","name":"Dar Zavain","position":1,"cik":"0001852075","reported_name":"Dar Zavain","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-06-05T22:11:43.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":13097,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units automatically granted pursuant to the Issuer's Outside Director Compensation Policy. The restricted stock units will vest on the earlier of June 3, 2025 or the day prior to the Issuer's 2025 annual meeting of stockholders, subject to Reporting Person's continued service to the Issuer."}],"balance_after":102153,"source":{"system":"sec-edgar","filing":"0001601830-24-000070","document":"wk-form4_1717625489.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852075/000160183024000070/wk-form4_1717625489.xml","form_type":"4"}},{"id":1550120,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":32942,"kind":"person","name":"Dar Zavain","position":1,"cik":"0001852075","reported_name":"Dar Zavain","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-04-03T21:43:01.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":1467,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares  were issued pursuant to the Issuer's  Outside Director Compensation Policy."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes a total of 32,373 shares received pursuant to a pro-rata distribution from Lux Ventures, of which the Reporting Person was a limited partner. The acquisition of such shares was exempt pursuant to Rule 16a-9 and was inadvertently excluded from the total amount of shares held on the Reporting Person's Forms 4 since July 12, 2023."}],"balance_after":89056,"source":{"system":"sec-edgar","filing":"0001601830-24-000029","document":"wk-form4_1712180571.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852075/000160183024000029/wk-form4_1712180571.xml","form_type":"4"}},{"id":1688250,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":32942,"kind":"person","name":"Dar Zavain","position":1,"cik":"0001852075","reported_name":"Dar Zavain","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-01-04T23:11:32.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":1393,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy"}],"balance_after":55216,"source":{"system":"sec-edgar","filing":"0001601830-24-000002","document":"wk-form4_1704409883.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852075/000160183024000002/wk-form4_1704409883.xml","form_type":"4"}},{"id":1707477,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":32942,"kind":"person","name":"Dar Zavain","position":1,"cik":"0001852075","reported_name":"Dar Zavain","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-12-18T23:44:12.000Z","date":"2023-12-14","kind":"sale","planned":true,"acquired":false,"shares":20141,"price":9,"value":181269.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on June 21, 2023"}],"balance_after":53823,"source":{"system":"sec-edgar","filing":"0001209191-23-059032","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852075/000120919123059032/doc4.xml","form_type":"4"}},{"id":1765492,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":32942,"kind":"person","name":"Dar Zavain","position":1,"cik":"0001852075","reported_name":"Dar Zavain","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-10-04T21:49:56.000Z","date":"2023-10-02","kind":"grant","planned":false,"acquired":true,"shares":1920,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy"}],"balance_after":73964,"source":{"system":"sec-edgar","filing":"0001209191-23-052066","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852075/000120919123052066/doc4.xml","form_type":"4"}},{"id":1834083,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":32942,"kind":"person","name":"Dar Zavain","position":1,"cik":"0001852075","reported_name":"Dar Zavain","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-07-06T22:08:18.000Z","date":"2023-07-03","kind":"grant","planned":false,"acquired":true,"shares":1863,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy"}],"balance_after":72044,"source":{"system":"sec-edgar","filing":"0001209191-23-041654","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852075/000120919123041654/doc4.xml","form_type":"4"}},{"id":1847989,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":32942,"kind":"person","name":"Dar Zavain","position":1,"cik":"0001852075","reported_name":"Dar Zavain","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-21T21:21:58.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":25224,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The shares subject to this option will vest and become exercisable on the earlier of June 16, 2024 or the date of the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":25224,"derivative":{"exercise_price":8.92,"exercise_date":"2024-06-16","expiration_date":"2033-06-16","underlying":"Class A Common Stock","underlying_shares":25224},"source":{"system":"sec-edgar","filing":"0001209191-23-038842","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1852075/000120919123038842/doc4.xml","form_type":"4"}},{"id":1847988,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":32942,"kind":"person","name":"Dar Zavain","position":1,"cik":"0001852075","reported_name":"Dar Zavain","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-06-21T21:21:58.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":12612,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units automatically granted pursuant to the Issuer's Outside Director Compensation Policy.  The restricted stock units will vest on the earlier of June 16, 2024 or the day prior to the Issuer's 2024 annual meeting of stockholders, subject to Reporting Person's continued service to the Issuer."}],"balance_after":70181,"source":{"system":"sec-edgar","filing":"0001209191-23-038842","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852075/000120919123038842/doc4.xml","form_type":"4"}},{"id":1911419,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":32942,"kind":"person","name":"Dar Zavain","position":1,"cik":"0001852075","reported_name":"Dar Zavain","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-04-28T20:34:05.000Z","date":"2023-04-03","kind":"grant","planned":false,"acquired":true,"shares":1996,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes a total of 35,008 shares received pursuant to a pro-rata distribution from Lux Ventures, of which the Reporting Person was a limited partner. The acquisition of such shares was exempt pursuant to Rule 16a-9 and was inadvertently excluded from the total amount of shares held on the original Form 4 filing."}],"balance_after":57569,"source":{"system":"sec-edgar","filing":"0001209191-23-026049","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852075/000120919123026049/doc4a.xml","form_type":"4/A","original_submission_date":"2023-04-05"}},{"id":1925339,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":32942,"kind":"person","name":"Dar Zavain","position":1,"cik":"0001852075","reported_name":"Dar Zavain","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-04-05T22:08:36.000Z","date":"2023-04-03","kind":"grant","planned":false,"acquired":true,"shares":1996,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy."}],"balance_after":22561,"source":{"system":"sec-edgar","filing":"0001209191-23-023436","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852075/000120919123023436/doc4.xml","form_type":"4"}},{"id":2208687,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":32942,"kind":"person","name":"Dar Zavain","position":1,"cik":"0001852075","reported_name":"Dar Zavain","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-07-12T21:01:27.000Z","date":"2022-07-08","kind":"other","acquired":true,"shares":2420,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro data distribution from Lux Ventures IV, L.P. and its affiliates, in a transaction which is exempt pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended."}],"balance_after":20565,"source":{"system":"sec-edgar","filing":"0001209191-22-041947","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852075/000120919122041947/doc4.xml","form_type":"4"}},{"id":2230211,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":32942,"kind":"person","name":"Dar Zavain","position":1,"cik":"0001852075","reported_name":"Dar Zavain","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-17T00:14:32.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":36290,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":36290,"derivative":{"exercise_price":6.2,"exercise_date":"2023-06-14","expiration_date":"2032-06-14","underlying":"Class A Common Stock","underlying_shares":36290},"source":{"system":"sec-edgar","filing":"0001209191-22-037635","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1852075/000120919122037635/doc4.xml","form_type":"4"}},{"id":2230210,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":32942,"kind":"person","name":"Dar Zavain","position":1,"cik":"0001852075","reported_name":"Dar Zavain","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-06-17T00:14:32.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":18145,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units automatically granted pursuant to the Issuer's Outside Director Compensation Policy.  The restricted stock units will vest on the earlier of June 14, 2023 or the day prior to the Issuer's 2023 annual meeting of stockholders."}],"balance_after":18145,"source":{"system":"sec-edgar","filing":"0001209191-22-037635","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852075/000120919122037635/doc4.xml","form_type":"4"}},{"id":2479087,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":32942,"kind":"person","name":"Dar Zavain","position":1,"cik":"0001852075","reported_name":"Dar Zavain","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A common stock","published_at":"2021-12-10T02:03:56.000Z","date":"2021-12-07","kind":"other","acquired":true,"shares":3599,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro data distribution from Lux Ventures IV, L.P. and its affiliates, in a transaction which is exempt pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended."}],"balance_after":3599,"source":{"system":"sec-edgar","filing":"0000905718-21-001585","document":"recursion_fm4dec72021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852075/000090571821001585/recursion_fm4dec72021.xml","form_type":"4"}}]}